Improving the Flexibility and Reactivity of your Supply Chain to Remove Waste and Cut the Cost of Global Clinical Trials
Increased complexity of clinical trials, entering into new regions, multiple site trials and differing regulatory requirements are all adding to the difficulties of getting the right supplies to the right places…on time!
What strategies are you putting in place to ensure efficiency in your supply chain and prevent over runs?
We recently conducted an industry wide survey to try and figure out how to achieve the efficiency and cost savings needed. Over 85% of you said that implementing IxRS systems and achieving a pooled supply approach, however, difficulties lie in choosing the right equipment and knowing which studies to pool. You spoke and we listened, creating a jam packed programme to give you all the latest case studies in the area.
About the Event – What’s New for 2012?
Last year’s inaugural event was an overwhelming success with comments ranging from ‘very interactive, great format’, to ‘highly valuable… a real eye opener!”. Indeed, the conference made such a good impression that we’ve already had 10 pharma representatives pre-register for the 2012 event - prior to it even going on sale. Well, this year’s programme doesn’t disappoint, providing you with the most interactive platform to discuss and address how to improve the flexibility and reactivity of your supply chain. With over 22 industry experts, an exclusive ISPE workshop and more than 8 hours worth of discussion and networking sessions, this is the perfect platform for learning, networking and benchmarking from others in the industry
What’s more, this year we’ve moved to Switzerland, the heart of pharma territory, and will again be running alongside our Cool Chain Logistics Europe event, now in its 11th year!
VIP PASSES
For Heads, Directors, VPs of Clinical Supply and Logistics
Enquire here to assess eligibility
New additions to the 2012 programme:
- ISPE workshop – an exclusive overview of the new whitepaper outlining best practice guidance for booklet design
- Non-IMP supply chain strategies – don’t let this be the rate limiting factor of your clinical trials!
- 121 Meetings; really get to know your peers and suppliers through a series of dedicated one to one sessions
- Process excellence within your supply chain? FDA are asking us to take a leaf out of other industrys’ books to ensure a robust and more flexible supply chain
- The clinical site perspective – understand what the site leader is looking for and enhancing communication with different players at the site
What others have to say:
“Good mix of Authority, Sponsor & vendor speakers.”-Sam Corveleyn, Actogenix
“Provided a good insight to the way large pharma are moving in initiating change in global clinical supply chain systems, processes.”-Deborah Williams, Brecon Pharmaceuticals Ltd
“Very valuable, good topics.”-G. Vleugels, Jansson Pharmaceutica
“Very valuable, gave me a very good overview as I am a beginner in
this field coming from drug substance development.”-Monika Huttenloch, MSD
“High value.”-Ida Jensen, NeuroSearch
“Excellent. Very valuable. Roundtables are an excellent ”-Amandeep Madra, GlaxoSmithKline
Where?
We've moved the event to one of Europe's most dense pharmaceutical and biotech hubs - Basel.
The Swiss biotech industry has achieved a much higher profile in recent years based on its record of success. Unlike many other industries Swiss biotech stood up remarkably well during the economic crisis, and in fact achieved significant growth with a total turnover in 2010 of CHF 9.2 billion
Good Practice When Designing Booklet Labels
We are pleased to announce an exclusive masterclass brought to you by members of the ISPE committee, who are releasing a new whitepaper outlining best practice approaches to designing your booklets labels. The industry’s biggest question will be discussed – what does the future hold for booklets and will they be eradicated?